Dipti Amin, Director at Lineage Cell Therapeutics, Inc. (LCTX), bought 70,000 shares at $1.63 ($114K) on 2022-03-28, disclosed to the SEC on 2022-03-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.63 | 35,000 | $57K | 50.0% |
| 2 | $1.63 | 35,000 | $57K | 50.0% |
| Total | $1.63 avg | 70,000 | $114K | 100% |